ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.

James L Mohler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.